OncoMed Pharmaceuticals Inc. (OMED) Declined -12.01% or -0.46 To Price $3.34 On Monday


OncoMed Pharmaceuticals Inc. (OMED) declined -12.01% or -0.46 to $3.34. It is near 213270 shares traded, which is 96.76% compare to the average total volume 220408. The market cap of OMED is $126.25 million. The year to date change is -3.07%. The 52 week price range is from $2.91 to $10.89. Price of OMED have changed -7.56% during last week. It have changed -23.74% over last month, -15.02% over last 3 months, 10.82% over last 6 months and -56.44% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for OMED is 4.36. It is 30.54% above current price. The 200-day Moving Averages for OMED is 4.41. It is 32.04% above current price. The 52-week High is 10.89. It is 226.05% from the current price. The 52-week Low is 2.91. It is -12.87% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of OMED is 4.3 on 2017-12-15. Short % to float is 2.91%. There are some statistics of OMED. It is has market cap $126.25 million. The share outstanding is 37.86 million. The average volume is 220408. The percent of top 15 Institution holding is 62.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of OMED is 216.92%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of OMED is -41.85%.


Tags:

Share this post